Skip to content

Generate Biomedicines

US · GENB #2875 by market cap Listed 2026
13.57 -0.23 -1.67%
Live - 5344 symbols - heartbeat 224s ago · 2026-10-08 07:21
Pre-market 13.57 0.00%
After-hours 13.57 0.00%
Overnight 13.71 +1.03%
Market cap
1.74B
P/B
3.82
EPS
-1.96
Reader sentiment Are you bullish or bearish on GENB?

Anonymous reader poll. Unscientific, not investment advice.

Analyst consensus 3 analysts

Buy
Avg price target 26.00 +91.6%
Price target rangecurrent 13.57
Low22.00
Avg26.00
High30.00
Buy 100% Hold 0% Sell 0%
Recent ratings (20)
DateFirmAnalystRatingTarget
2026-10-05 H.C. Wainwright -- BUY 30.00
2026-10-02 Piper Sandler -- BUY 26.00
2026-09-09 H.C. Wainwright -- BUY 30.00
2026-09-08 H.C. Wainwright -- BUY 30.00
2026-08-28 H.C. Wainwright -- BUY 30.00
2026-08-17 Morgan Stanley -- BUY 22.00
2026-08-07 Piper Sandler -- BUY 24.00
2026-08-07 H.C. Wainwright -- BUY 25.00
2026-06-24 Guggenheim -- BUY 30.00
2026-06-15 Guggenheim -- BUY 30.00
2026-05-14 Morgan Stanley -- BUY 22.00
2026-05-08 Piper Sandler -- BUY 24.00
2026-05-08 H.C. Wainwright -- BUY 25.00
2026-04-13 H.C. Wainwright -- BUY 16.00
2026-04-09 Goldman Sachs -- BUY 26.00
2026-03-24 Cantor Fitzgerald -- BUY --
2026-03-24 Piper Sandler -- BUY 24.00
2026-03-24 Morgan Stanley -- BUY 20.00
2026-03-24 Goldman Sachs -- BUY 13.75
2026-03-24 Guggenheim -- BUY 30.00

Quant vs Street three independent views, side by side

Momentum strategy signal
Hold
Analyst consensus
Buy

Signals diverge - worth digging into why.

Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.

Price target trend monthly average, last 3 years

Quote time 2026-10-08 07:21:33 · For reference only, not investment advice and not tailored to your situation.